Oct parameters as predictive factors for the visual outcome after ranibizumab therapy in neovascular age related macular degeneration.

PMID:25620678
Valverde-Megías A , Donate-López J , García-Gil-de-Bernabé J , Megías-Fresno A , García-Feijoo J
Archivos de la Sociedad Española de Oftalmología
To evaluate macular morphological parameters measured by spectral domain optical coherence tomography (SD-OCT) as predictive factors of visual outcome in patients with exudative age-related macular degeneration (AMD) treated with ranibizumab.


Copyright(C) 2006 BIOIMPACT Co., Ltd. All Rights Reserved